Clinical trial
S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or…
NCT00233987 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00233987 |
|---|---|
| Title | S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma |
| Official title | Tandem Autologous Stem Cell Transplantation for Patients With Primary Progressive or Recurrent Hodgkin's Disease (A BMT Study), Phase II |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | carmustine, cyclophosphamide, etoposide, melphalan, autologous-autologous tandem hematopoietic stem cell transplantation, radiation therapy |
| Enrollment | 98 |
| Start date | Oct 1, 2005 |
| Primary completion | Nov 1, 2014 |
| Completion | Dec 1, 2017 |
| First posted | Oct 6, 2005 |
| Last update posted | Mar 1, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: